Single Photon Emission Computed Tomography (SPECT) Market
Single Photon Emission Computed Tomography (SPECT) Market Analysis By Product (Standalone & Hybrid) By Radioisotpe (Tc-99m, Ra-223, Ga-67, I-123 & Others) By Application (Cardiology, Oncology, Neurology & Others) By End-User & Region – Global Insights 2022 to 2026
Analysis of Single Photon Emission Computed Tomography (SPECT) market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Single Photon Emission Computed Tomography (SPECT) Market Outlook (2022 to 2026)
Expanding at a CAGR of 6.8%, the global single photon emission computed tomography (SPECT) market is projected to increase from a valuation of US$ 2 billion in 2022 to US$ 2.6 billion by the end of 2026.
The cardiology application segment is anticipated to increase at a significant rate during the forecast period (2022 to 2026). Increasing prevalence of cardiovascular disorders, rising adoption of cardiovascular OCT imaging techniques, and growing public awareness about heart disease diagnosis are reasons for rapid segmental growth.
| Report Attributes | Details |
|---|---|
| Single Photon Emission Computed Tomography Market Size (2022) | US$ 2 Billion |
| Projected Market Value (2026) | US$ 2.6 Billion |
| Global Market Growth Rate (2022 to 2026) | 6.8% CAGR |
| Market Share of Standalone Systems | 55% |
| Key Companies Profiled | Bracco Imaging; Siemens Healthcare; Novartis AG; Mediso Ltd.; Bruker Corporation; Cadinal Health Inc.; Curium; DDD-Diagnostic A/S; Digirad Corporation; GE Healthcare (GE Company); Koninklijke Philips N.V.; MiE America, Inc.; Spectrum Dynamics Medical; Beijing Hamamatsu Photon Techniques Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Single Photon Emission Computed Tomography (2017 to 2021) Vs. Market Outlook (2022 to 2026)
“Increasing Investments in Advanced SPECT Scanning Services”
According to Fact.MR, a market research and competitive intelligence provider, demand for single photon emission computed tomography systems is expected to increase at a CAGR of 6.8% from 2022 to 2026.
A nuclear imaging scan uses a radioactive tracer and computed tomography (CT) to produce a diagnostic. By producing gamma rays that the CT scanner can detect, the radiolabeled tracer enables medical personnel to evaluate how blood passes to organs and tissues.
Gamma ray emissions are used to generate data, which is subsequently shown on CT cross-sections by computers. These cross-sections are used to represent the brain and other organs in three dimensions.
Using cardiac single photon emission computed tomography scans, the blood flow through the heart is assessed; areas of the heart with insufficient blood flow will appear dark, whereas areas with normal blood flow would seem light.
Additionally, it is employed in the diagnosis of concealed bone fractures, including stress fractures and shin splints. The single emission computed tomography market is expanding due to rising investments in advanced SPECT scanning services and growing public awareness about disease diagnosis.
Which Key Market Factors are Driving Demand for Single Photon Emission Computed Tomography Systems?
“Rising Need for Accurate System Calibration & Operation for Better-quality Outcomes Driving Market Value”
A single photon emission computed tomography scan can identify blood flow through arteries and veins in the brain and spine. Single photon emission computed tomography systems may provide better accurate results for brain injury because they are used to identify decreased blood flow to injured regions.
Recent advancements in medical imaging have made the combination of X-ray computed tomography (CT) and single photon emission computed tomography a vital diagnostic tool where anatomical details can distinguish between functional and metabolic data.
Single photon emission computed tomography systems can be useful in the identification of attacks, tremors, and Alzheimer's disease, among other conditions. Both 2D and 3D images are produced using single photon emission computed tomography scanners. Rising need for accurate system calibration and operation for better-quality outcomes driving the demand for tomographic imaging techniques.
The market is expanding as a result of advancements in single photon emission computed tomography technology as well as rising incidence of cardiovascular and cancer disorders across the world.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are the Challenging Factors for Market Expansion?
“Lack of Funding for Advanced Medical Facilities & Side Effects of Radiopharmaceuticals”
Market expansion is anticipated to be hampered by the radioisotopes' shorter half-lives, the lack of essential healthcare services, the high price of reagents, side effects of radiopharmaceuticals, and susceptibility to storage conditions.
While molecular isotopes are necessary for diagnostic imaging services, their scarcity and inadequate supply are projected to limit the growth of the worldwide single photon emission computed tomography market throughout the projection period.
Another element that is having a detrimental effect on the global market for SPECT is product recalls. Adverse consequences are linked to the use of single photon emission tomography devices in the diagnosis, staging, restaging, and follow-up of lesions, illnesses, and organ dysfunctions, including cancer, cardiovascular disease, and brain dysfunction.
The emission computed tomography market is experiencing difficulties in terms of revenue growth due to product recalls because of the negative consequences of single photon emission computed tomography devices.
Poor health care systems and lack of funding for advanced medical facilities are also anticipated to impede expansion of the market over the forecast period.
How are Start-ups Contributing to Market Expansion?
“New Market Entrants Focused on Development of 3D Imaging Methods for Better Diagnosis”
Image screening frequently makes it feasible to find cancer early on. However, because cancer cells are surrounded by other cells, two-dimensional images do not fully capture the situation.
Consequently, 3D imaging of cancer cells is becoming a tool for better diagnosis. New companies are developing such methods to record even the smallest details of tumors.
- Survon, a start-up based in the U.S., can examine individual live cancer cells in three dimensions using micro-computed tomography (micro-CT) technology. The business employs computer vision to extract information and changes at the microscopic level from 3D photos of cancer cells. The technology uses machine learning to produce a personalized digital representation of the tumor, enabling doctors to track, evaluate, and forecast.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Which Region Dominates the SPECT Market?
“Increase in Awareness Campaigns for Cancer and Cardiovascular Illnesses in North America”
North America holds the highest share in the single photon emission computed tomography market. The huge ageing population, high prevalence of cancer cases, and a high number of cardiac patients are all driving market growth in the region.
The market in North America is driven by the growing usage of emission computerized tomography systems for the early detection and treatment of disease.
The presence of prominent players, favorable regulations on radiopharmaceutical products, supportive government policies related to health care infrastructure, and a rise in awareness campaigns for cancer and cardiovascular illnesses are the primary drivers boosting market expansion in the region.
Country-wise Insights
How Will the SPECT Market Perform in the U.S.?
“Recent Advances in Molecular Imaging Driving Market Growth in the U.S.”
Advances in molecular imaging, the emergence of new radiopharmaceuticals for diagnostics, and other technological breakthroughs are driving the growth of the single photon emission computed tomography market in the United States.
Rapid expansion of the healthcare industry, the rising prevalence of coronary artery disorders, rising adoption of dual-modality and organ-specific systems are driving the market growth.
Why is the China SPECT Market Expected to Be Highly Lucrative?
“Introduction of Novel Radionuclides for Diagnostics to Drive Market Growth in China”
The single photon emission computed tomography market in China is projected to increase at a CAGR of 9% from 2022 to 2026.
The China SPECT market is anticipated to expand quickly due to the growing population, changing lifestyles, increased patient awareness, and rising per capita spending. The expansion of pharmaceutical distribution channels and improvements in health care infrastructure are the factors projected to fuel market expansion in China.
The market in China is expanding due to technological advancements such as multimodal imaging, introduction of novel radionuclides for diagnostics, and rising demand for better imaging devices.
Category-wise Insights
Which SPECT Product is Expected to Hold a Dominant Market Share?
“Standalone Systems Widely Preferred for Precise Illness Staging and Early Disease Diagnosis”
Based on product, the single photon emission computed tomography market is classified into standalone and hybrid. Standalone systems account for 55% share of the global market. Standalone systems are most frequently used, particularly in oncology and cardiology applications.
The device can create high full-body tomographic images in real-time and identifies the gamma-ray emissions from an injected radioisotope to generate images for diagnosis and illness management.
Additional benefits of standalone systems include precise illness staging and early diagnosis. In recent years, technological innovations for standalone systems have increased as well.
Which Radioisotope Accounts for Highest Revenue Generation?
“Growing Usage of Ga-67 Radioisotope for Imaging of Inflammation”
On the basis of radioisotope, the market is segmented into Tc-99m, Ra-223, Ga-67, I-123, and others.
Inflammation and infections such as Hodgkin's disease, lymphomas other than lymphocytic ones, hepatomas, and bronchogenic carcinoma are all diagnosed with the gallium-67 radioisotope. It serves primarily as a bone imaging agent.
Ga-67 radioisotope offers accurate localization of lymphoma lesions. Ga-67 is a frequently utilized agent for the imaging of inflammation. Rising incidence of cancer, driving the demand for Ga-67 radioisotopes for disease diagnosis and treatment.
Competitive Landscape
Key market players can supply items that are both safe and efficient since they have sufficient resources and technical expertise. Most of the major vendors have been observed investing a significant percentage of their funding in product R&D.
Additionally, they are concentrating on organic development initiatives, such as product launches, to significantly differentiate their offerings and increase client penetration. By employing price-cutting techniques and expanding their local clientele, small-scale suppliers are competing with established market players.
For instance :
- In 2022, with two pipeline radiopharmaceuticals - one for Positron Emission Tomography (PET) and the other for single-photon release calculated tomography imaging - GE Healthcare intends to expand its product line. Recently, the company announced that the first patient had been given medication in a Phase III clinical trial for a PET radiopharmaceutical imaging intermediary that aims to help with the evaluation of adult patients with alleged Parkinsonian syndromes, provide research, and enhance patient maintenance.
Single Photon Emission Computed Tomography Industry Research Segmentation
-
By Product :
- Standalone
- Hybrid
-
By Radioisotope :
- Tc-99m
- Ra-223
- Ga-67
- I-123
- Others
-
By Application :
- Cardiology
- Oncology
- Neurology
- Others
-
By End User :
- Hospitals
- Diagnostic Centers
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Pricing Analysis
- 5. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2026)
- 6. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2026), by Radioisotope
- 6.1. Tc-99m
- 6.2. Ra-223
- 6.3. Ga-67
- 6.4. I-123
- 6.5. Others
- 7. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2026), by Product
- 7.1. Standalone
- 7.2. Hybrid
- 8. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2026), by Application
- 8.1. Cardiology
- 8.2. Oncology
- 8.3. Neurology
- 8.4. Others
- 9. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2026), by End User
- 9.1. Hospitals
- 9.2. Diagnostic Centers
- 9.3. Others
- 10. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2026), by Region
- 10.1. North America
- 10.2. Europe
- 10.3. East Asia
- 10.4. South Asia
- 10.5. Latin America
- 10.6. Middle East & Africa (MEA)
- 10.7. Oceania
- 11. North America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. East Asia Market Analysis and Forecast
- 14. South Asia Market Analysis and Forecast
- 15. Latin America Market Analysis and Forecast
- 16. Middle East & Africa Market Analysis and Forecast
- 17. Oceania Market Analysis and Forecast
- 18. Global Market Analysis Key Countries
- 19. Competition Landscape
- 20. Competition Analysis
- 20.1. Bracco Imaging
- 20.2. Siemens Healthcare
- 20.3. Novartis AG
- 20.4. Mediso Ltd.
- 20.5. Bruker Corporation
- 20.6. Cardinal Health Inc.
- 20.7. Curium
- 20.8. DDD-Diagnostic A/S
- 20.9. Digirad Corporation
- 20.10. GE Healthcare (GE Company)
- 20.11. Koninklijke Philips N.V.
- 20.12. MiE America, Inc.
- 20.13. Spectrum Dynamics Medical
- 20.14. Beijing Hamamatsu Photon Techniques Inc.
- 21. Appendix
- 22. Definitions of Analytical Frameworks
- 23. Sources and References
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (Units), by Radioisotope, 2017 to 2026
Table 02: Global Market Value (US$ Mn), by Radioisotope, 2017 to 2026
Table 03: Global Market Volume (Units), by Product, 2017 to 2026
Table 04: Global Market Value (US$ Mn), by Product, 2017 to 2026
Table 05: Global Market Volume (Units), by Application, 2017 to 2026
Table 06: Global Market Value (US$ Mn), by Application, 2017 to 2026
Table 07: Global Market Volume (Units), by End User, 2017 to 2026
Table 08: Global Market Value (US$ Mn), by End User, 2017 to 2026
Table 09: Global Market Volume (Units), by Region, 2017 to 2026
Table 10: Global Market Value (US$ Mn), by Region, 2017 to 2026
Table 11: North America Market Volume (Units), by Radioisotope, 2017 to 2026
Table 12: North America Market Value (US$ Mn), by Radioisotope, 2017 to 2026
Table 13: North America Market Volume (Units), by Product, 2017 to 2026
Table 14: North America Market Value (US$ Mn), by Product, 2017 to 2026
Table 15: North America Market Volume (Units), by Application, 2017 to 2026
Table 16: North America Market Value (US$ Mn), by Application, 2017 to 2026
Table 17: North America Market Volume (Units), by End User, 2017 to 2026
Table 18: North America Market Value (US$ Mn), by End User, 2017 to 2026
Table 19: North America Market Volume (Units), by Country, 2017 to 2026
Table 20: North America Market Value (US$ Mn), by Country, 2017 to 2026
Table 21: Europe Market Volume (Units), by Radioisotope, 2017 to 2026
Table 22: Europe Market Value (US$ Mn), by Radioisotope, 2017 to 2026
Table 23: Europe Market Volume (Units), by Product, 2017 to 2026
Table 24: Europe Market Value (US$ Mn), by Product, 2017 to 2026
Table 25: Europe Market Volume (Units), by Application, 2017 to 2026
Table 26: Europe Market Value (US$ Mn), by Application, 2017 to 2026
Table 27: Europe Market Volume (Units), by End User, 2017 to 2026
Table 28: Europe Market Value (US$ Mn), by End User, 2017 to 2026
Table 29: Europe Market Volume (Units), by Country, 2017 to 2026
Table 30: Europe Market Value (US$ Mn), by Country, 2017 to 2026
Table 31: East Asia Market Volume (Units), by Radioisotope, 2017 to 2026
Table 32: East Asia Market Value (US$ Mn), by Radioisotope, 2017 to 2026
Table 33: East Asia Market Volume (Units), by Product, 2017 to 2026
Table 34: East Asia Market Value (US$ Mn), by Product, 2017 to 2026
Table 35: East Asia Market Volume (Units), by Application, 2017 to 2026
Table 36: East Asia Market Value (US$ Mn), by Application, 2017 to 2026
Table 37: East Asia Market Volume (Units), by End User, 2017 to 2026
Table 38: East Asia Market Value (US$ Mn), by End User, 2017 to 2026
Table 39: East Asia Market Volume (Units), by Country, 2017 to 2026
Table 40: East Asia Market Value (US$ Mn), by Country, 2017 to 2026
Table 41: South Asia Market Volume (Units), by Radioisotope, 2017 to 2026
Table 42: South Asia Market Value (US$ Mn), by Radioisotope, 2017 to 2026
Table 43: South Asia Market Volume (Units), by Product, 2017 to 2026
Table 44: South Asia Market Value (US$ Mn), by Product, 2017 to 2026
Table 45: South Asia Market Volume (Units), by Application, 2017 to 2026
Table 46: South Asia Market Value (US$ Mn), by Application, 2017 to 2026
Table 47: South Asia Market Volume (Units), by End User, 2017 to 2026
Table 48: South Asia Market Value (US$ Mn), by End User, 2017 to 2026
Table 49: South Asia Market Volume (Units), by Country, 2017 to 2026
Table 50: South Asia Market Value (US$ Mn), by Country, 2017 to 2026
Table 51: Latin America Market Volume (Units), by Radioisotope, 2017 to 2026
Table 52: Latin America Market Value (US$ Mn), by Radioisotope, 2017 to 2026
Table 53: Latin America Market Volume (Units), by Product, 2017 to 2026
Table 54: Latin America Market Value (US$ Mn), by Product, 2017 to 2026
Table 55: Latin America Market Volume (Units), by Application, 2017 to 2026
Table 56: Latin America Market Value (US$ Mn), by Application, 2017 to 2026
Table 57: Latin America Market Volume (Units), by End User, 2017 to 2026
Table 58: Latin America Market Value (US$ Mn), by End User, 2017 to 2026
Table 59: Latin America Market Volume (Units), by Country, 2017 to 2026
Table 60: Latin America Market Value (US$ Mn), by Country, 2017 to 2026
Table 61: Middle East and Africa Market Volume (Units), by Radioisotope, 2017 to 2026
Table 62: Middle East and Africa Market Value (US$ Mn), by Radioisotope, 2017 to 2026
Table 63: Middle East and Africa Market Volume (Units), by Product, 2017 to 2026
Table 64: Middle East and Africa Market Value (US$ Mn), by Product, 2017 to 2026
Table 65: Middle East and Africa Market Volume (Units), by Application, 2017 to 2026
Table 66: Middle East and Africa Market Value (US$ Mn), by Application, 2017 to 2026
Table 67: Middle East and Africa Market Volume (Units), by End User, 2017 to 2026
Table 68: Middle East and Africa Market Value (US$ Mn), by End User, 2017 to 2026
Table 69: Middle East and Africa Market Volume (Units), by Country, 2017 to 2026
Table 70: Middle East and Africa Market Value (US$ Mn), by Country, 2017 to 2026
Table 71: Oceania Market Volume (Units), by Radioisotope, 2017 to 2026
Table 72: Oceania Market Value (US$ Mn), by Radioisotope, 2017 to 2026
Table 73: Oceania Market Volume (Units), by Product, 2017 to 2026
Table 74: Oceania Market Value (US$ Mn), by Product, 2017 to 2026
Table 75: Oceania Market Volume (Units), by Application, 2017 to 2026
Table 76: Oceania Market Value (US$ Mn), by Application, 2017 to 2026
Table 77: Oceania Market Volume (Units), by End User, 2017 to 2026
Table 78: Oceania Market Value (US$ Mn), by End User, 2017 to 2026
Table 79: Oceania Market Volume (Units), by Country, 2017 to 2026
Table 80: Oceania Market Value (US$ Mn), by Country, 2017 to 2026
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Fig 01: Global Market Volume (Units), Value (US$ Thousand) and Y-o-Y Growth, 2017 to 2026
Fig 02: Global Absolute $ Historical Market (2017 to 2021) and Absolute $ Opportunity (2022 to 2026), US$ Mn
Fig 03: Global Absolute Historical Volume Market (2017 to 2021) and Absolute Volume Opportunity (2022 to 2026), Units
Fig 04: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2026
Fig 05: Global Market Incremental $ Opportunity (US$ Thousand), 2022 to 2026
Fig 06: Global Market Share, By Radioisotope to 2022 to 2026
Fig 07: Global Market Y-o-Y Growth Projections, By Radioisotope to 2022 to 2026
Fig 08: Global Market Attractiveness Index, By Radioisotope to 2022 to 2026
Fig 09: Global Market Share, By Product to 2022 to 2026
Fig 10: Global Market Y-o-Y Growth Projections, By Product to 2022 to 2026
Fig 11: Global Market Attractiveness Index, By Product to 2022 to 2026
Fig 12: Global Market Share, By Application to 2022 to 2026
Fig 13: Global Market Y-o-Y Growth Projections, By Application to 2022 to 2026
Fig 14: Global Market Attractiveness Index, By Application to 2022 to 2026
Fig 15: Global Market Share, By End User to 2022 to 2026
Fig 16: Global Market Y-o-Y Growth Projections, By End User to 2022 to 2026
Fig 17: Global Market Attractiveness Index, By End User to 2022 to 2026
Fig 18: Global Market Share, by Region to 2022 to 2026
Fig 19: Global Market Y-o-Y Growth Projections, by Region to 2022 to 2026
Fig 20: Global Market Attractiveness Index, by Region to 2022 to 2026
Fig 21: North America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2026
Fig 22: Y-o-Y Growth Comparison of Market: North America Vs North America Countries Vs North America Average
Fig 23: North America Market Share, By Radioisotope to 2022 to 2026
Fig 24: North America Market Y-o-Y Growth Projections, By Radioisotope to 2022 to 2026
Fig 25: North America Market Attractiveness Index, By Radioisotope to 2022 to 2026
Fig 26: North America Market Share, By Product to 2022 to 2026
Fig 27: North America Market Y-o-Y Growth Projections, By Product to 2022 to 2026
Fig 28: North America Market Attractiveness Index, By Product to 2022 to 2026
Fig 29: North America Market Share, By Application to 2022 to 2026
Fig 30: North America Market Y-o-Y Growth Projections, By Application to 2022 to 2026
Fig 31: North America Market Attractiveness Index, By Application to 2022 to 2026
Fig 32: North America Market Share, By End User to 2022 to 2026
Fig 33: North America Market Y-o-Y Growth Projections, By End User to 2022 to 2026
Fig 34: North America Market Attractiveness Index, By End User to 2022 to 2026
Fig 35: North America Market Share, By Country to 2022 to 2026
Fig 36: North America Market Y-o-Y Growth Projections, By Country to 2022 to 2026
Fig 37: North America Market Attractiveness Index, By Country to 2022 to 2026
Fig 38: Europe Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2026
Fig 39: Y-o-Y Growth Comparison of Market: Europe Vs Europe Countries Vs Europe Average
Fig 40: Europe Market Share, By Radioisotope to 2022 to 2026
Fig 41: Europe Market Y-o-Y Growth Projections, By Radioisotope to 2022 to 2026
Fig 42: Europe Market Attractiveness Index, By Radioisotope to 2022 to 2026
Fig 43: Europe Market Share, By Product to 2022 to 2026
Fig 44: Europe Market Y-o-Y Growth Projections, By Product to 2022 to 2026
Fig 45: Europe Market Attractiveness Index, By Product to 2022 to 2026
Fig 46: Europe Market Share, By Application to 2022 to 2026
Fig 47: Europe Market Y-o-Y Growth Projections, By Application to 2022 to 2026
Fig 48: Europe Market Attractiveness Index, By Application to 2022 to 2026
Fig 49: Europe Market Share, By End User to 2022 to 2026
Fig 50: Europe Market Y-o-Y Growth Projections, By End User to 2022 to 2026
Fig 51: Europe Market Attractiveness Index, By End User to 2022 to 2026
Fig 52: Europe Market Share, By Country to 2022 to 2026
Fig 53: Europe Market Y-o-Y Growth Projections, By Country to 2022 to 2026
Fig 54: Europe Market Attractiveness Index, By Country to 2022 to 2026
Fig 55: East Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2026
Fig 56: Y-o-Y Growth Comparison of Market: East Asia Vs East Asia Countries Vs East Asia Average
Fig 57: East Asia Market Share, By Radioisotope to 2022 to 2026
Fig 58: East Asia Market Y-o-Y Growth Projections, By Radioisotope to 2022 to 2026
Fig 59: East Asia Market Attractiveness Index, By Radioisotope to 2022 to 2026
Fig 60: East Asia Market Share, By Product to 2022 to 2026
Fig 61: East Asia Market Y-o-Y Growth Projections, By Product to 2022 to 2026
Fig 62: East Asia Market Attractiveness Index, By Product to 2022 to 2026
Fig 63: East Asia Market Share, By Application to 2022 to 2026
Fig 64: East Asia Market Y-o-Y Growth Projections, By Application to 2022 to 2026
Fig 65: East Asia Market Attractiveness Index, By Application to 2022 to 2026
Fig 66: East Asia Market Share, By End User to 2022 to 2026
Fig 67: East Asia Market Y-o-Y Growth Projections, By End User to 2022 to 2026
Fig 68: East Asia Market Attractiveness Index, By End User to 2022 to 2026
Fig 69: East Asia Market Share, By Country to 2022 to 2026
Fig 70: East Asia Market Y-o-Y Growth Projections, By Country to 2022 to 2026
Fig 71: East Asia Market Attractiveness Index, By Country to 2022 to 2026
Fig 72: South Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2026
Fig 73: Y-o-Y Growth Comparison of Market: South Asia Vs South Asia Countries Vs South Asia Average
Fig 74: South Asia Market Share, By Radioisotope to 2022 to 2026
Fig 75: South Asia Market Y-o-Y Growth Projections, By Radioisotope to 2022 to 2026
Fig 76: South Asia Market Attractiveness Index, By Radioisotope to 2022 to 2026
Fig 77: South Asia Market Share, By Product to 2022 to 2026
Fig 78: South Asia Market Y-o-Y Growth Projections, By Product to 2022 to 2026
Fig 79: South Asia Market Attractiveness Index, By Product to 2022 to 2026
Fig 80: South Asia Market Share, By Application to 2022 to 2026
Fig 81: South Asia Market Y-o-Y Growth Projections, By Application to 2022 to 2026
Fig 82: South Asia Market Attractiveness Index, By Application to 2022 to 2026
Fig 83: South Asia Market Share, By End User to 2022 to 2026
Fig 84: South Asia Market Y-o-Y Growth Projections, By End User to 2022 to 2026
Fig 85: South Asia Market Attractiveness Index, By End User to 2022 to 2026
Fig 86: South Asia Market Share, By Country to 2022 to 2026
Fig 87: South Asia Market Y-o-Y Growth Projections, By Country to 2022 to 2026
Fig 88: South Asia Market Attractiveness Index, By Country to 2022 to 2026
Fig 89: Latin America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2026
Fig 90: Y-o-Y Growth Comparison of Market: Latin America Vs Latin America Countries Vs Latin America Average
Fig 91: Latin America Market Share, By Radioisotope to 2022 to 2026
Fig 92: Latin America Market Y-o-Y Growth Projections, By Radioisotope to 2022 to 2026
Fig 93: Latin America Market Attractiveness Index, By Radioisotope to 2022 to 2026
Fig 94: Latin America Market Share, By Product to 2022 to 2026
Fig 95: Latin America Market Y-o-Y Growth Projections, By Product to 2022 to 2026
Fig 96: Latin America Market Attractiveness Index, By Product to 2022 to 2026
Fig 97: Latin America Market Share, By Application to 2022 to 2026
Fig 98: Latin America Market Y-o-Y Growth Projections, By Application to 2022 to 2026
Fig 99: Latin America Market Attractiveness Index, By Application to 2022 to 2026
Fig 100: Latin America Market Share, By End User to 2022 to 2026
Fig 101: Latin America Market Y-o-Y Growth Projections, By End User to 2022 to 2026
Fig 102: Latin America Market Attractiveness Index, By End User to 2022 to 2026
Fig 103: Latin America Market Share, By Country to 2022 to 2026
Fig 104: Latin America Market Y-o-Y Growth Projections, By Country to 2022 to 2026
Fig 105: Latin America Market Attractiveness Index, By Country to 2022 to 2026
Fig 106: MEA Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2026
Fig 107: Y-o-Y Growth Comparison of Market: MEA Vs MEA Countries Vs MEA Average
Fig 108: MEA Market Share, By Radioisotope to 2022 to 2026
Fig 109: MEA Market Y-o-Y Growth Projections, By Radioisotope to 2022 to 2026
Fig 110: MEA Market Attractiveness Index, By Radioisotope to 2022 to 2026
Fig 111: MEA Market Share, By Product to 2022 to 2026
Fig 112: MEA Market Y-o-Y Growth Projections, By Product to 2022 to 2026
Fig 113: MEA Market Attractiveness Index, By Product to 2022 to 2026
Fig 114: MEA Market Share, By Application to 2022 to 2026
Fig 115: MEA Market Y-o-Y Growth Projections, By Application to 2022 to 2026
Fig 116: MEA Market Attractiveness Index, By Application to 2022 to 2026
Fig 117: MEA Market Share, By End User to 2022 to 2026
Fig 118: MEA Market Y-o-Y Growth Projections, By End User to 2022 to 2026
Fig 119: MEA Market Attractiveness Index, By End User to 2022 to 2026
Fig 120: MEA Market Share, By Country to 2022 to 2026
Fig 121: MEA Market Y-o-Y Growth Projections, By Country to 2022 to 2026
Fig 122: MEA Market Attractiveness Index, By Country to 2022 to 2026
Fig 123: Oceania Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2026
Fig 124: Y-o-Y Growth Comparison of Market: Oceania Vs Oceania Countries Vs Oceania Average
Fig 125: Oceania Market Share, By Radioisotope to 2022 to 2026
Fig 126: Oceania Market Y-o-Y Growth Projections, By Radioisotope to 2022 to 2026
Fig 127: Oceania Market Attractiveness Index, By Radioisotope to 2022 to 2026
Fig 128: Oceania Market Share, By Product to 2022 to 2026
Fig 129: Oceania Market Y-o-Y Growth Projections, By Product to 2022 to 2026
Fig 130: Oceania Market Attractiveness Index, By Product to 2022 to 2026
Fig 131: Oceania Market Share, By Application to 2022 to 2026
Fig 132: Oceania Market Y-o-Y Growth Projections, By Application to 2022 to 2026
Fig 133: Oceania Market Attractiveness Index, By Application to 2022 to 2026
Fig 134: Oceania Market Share, By End User to 2022 to 2026
Fig 135: Oceania Market Y-o-Y Growth Projections, By End User to 2022 to 2026
Fig 136: Oceania Market Attractiveness Index, By End User to 2022 to 2026
Fig 137: Oceania Market Share, By Country to 2022 to 2026
Fig 138: Oceania Market Y-o-Y Growth Projections, By Country to 2022 to 2026
Fig 139: Oceania Market Attractiveness Index, By Country to 2022 to 2026
Fig 140: United States Market share by Radioisotope, 2022
Fig 141: United States Market share by Product, 2022
Fig 142: United States Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 143: United States Market Share by End User, 2022
Fig 144: Canada Market share by Radioisotope, 2022
Fig 145: Canada Market share by Product, 2022
Fig 146: Canada Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 147: Canada Market Share by End User, 2022
Fig 148: Germany Market share by Radioisotope, 2022
Fig 149: Germany Market share by Product, 2022
Fig 150: Germany Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 151: Germany Market Share by End User, 2022
Fig 152: United Kingdom Market share by Radioisotope, 2022
Fig 153: United Kingdom Market share by Product, 2022
Fig 154: United Kingdom Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 155: United Kingdom Market Share by End User, 2022
Fig 156: France Market share by Radioisotope, 2022
Fig 157: France Market share by Product, 2022
Fig 158: France Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 159: France Market Share by End User, 2022
Fig 160: Russia Market share by Radioisotope, 2022
Fig 161: Russia Market share by Product, 2022
Fig 162: Russia Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 163: Russia Market Share by End User, 2022
Fig 164: Spain Market share by Radioisotope, 2022
Fig 165: Spain Market share by Product, 2022
Fig 166: Spain Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 167: Spain Market Share by End User, 2022
Fig 168: Italy Market share by Radioisotope, 2022
Fig 169: Italy Market share by Product, 2022
Fig 170: Italy Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 171: Italy Market Share by End User, 2022
Fig 172: China Market share by Radioisotope, 2022
Fig 173: China Market share by Product, 2022
Fig 174: China Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 175: China Market Share by End User, 2022
Fig 176: Japan Market share by Radioisotope, 2022
Fig 177: Japan Market share by Product, 2022
Fig 178: Japan Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 179: Japan Market Share by End User, 2022
Fig 180: South Korea Market share by Radioisotope, 2022
Fig 181: South Korea Market share by Product, 2022
Fig 182: South Korea Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 183: South Korea Market Share by End User, 2022
Fig 184: India Market share by Radioisotope, 2022
Fig 185: India Market share by Product, 2022
Fig 186: India Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 187: India Market Share by End User, 2022
Fig 188: Singapore Market share by Radioisotope, 2022
Fig 189: Singapore Market share by Product, 2022
Fig 190: Singapore Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 191: Singapore Market Share by End User, 2022
Fig 192: Indonesia Market share by Radioisotope, 2022
Fig 193: Indonesia Market share by Product, 2022
Fig 194: Indonesia Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 195: Indonesia Market Share by End User, 2022
Fig 196: Thailand Market share by Radioisotope, 2022
Fig 197: Thailand Market share by Product, 2022
Fig 198: Thailand Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 199: Thailand Market Share by End User, 2022
Fig 200: Brazil Market share by Radioisotope, 2022
Fig 201: Brazil Market share by Product, 2022
Fig 202: Brazil Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 203: Brazil Market Share by End User, 2022
Fig 204: Mexico Market share by Radioisotope, 2022
Fig 205: Mexico Market share by Product, 2022
Fig 206: Mexico Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 207: Mexico Market Share by End User, 2022
Fig 208: Turkey Market share by Radioisotope, 2022
Fig 209: Turkey Market share by Product, 2022
Fig 210: Turkey Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 211: Turkey Market Share by End User, 2022
Fig 212: GCC Countries Market share by Radioisotope, 2022
Fig 213: GCC Countries Market share by Product, 2022
Fig 214: GCC Countries Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 215: GCC Countries Market Share by End User, 2022
Fig 216: South Africa Market share by Radioisotope, 2022
Fig 217: South Africa Market share by Product, 2022
Fig 218: South Africa Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 219: South Africa Market Share by End User, 2022
Fig 220: Australia Market share by Radioisotope, 2022
Fig 221: Australia Market share by Product, 2022
Fig 222: Australia Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 223: Australia Market Share by End User, 2022
Fig 224: New Zealand Market share by Radioisotope, 2022
Fig 225: New Zealand Market share by Product, 2022
Fig 226: New Zealand Market Value (US$ Mn) and Forecast 2022 to 2026
Fig 227: New Zealand Market Share by End User, 2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the single photon emission computed tomography market?
The global single photon emission computed tomography market is valued at US$ 2 billion.
What valuation is the SPECT market expected to reach by 2026?
By 2026, the SPECT market is predicted to reach US$ 2.6 billion.
What is the predicted growth rate of the SPECT market?
The market for SPECT is anticipated to rise at 6.8% CAGR through 2026.
Which are the prominent companies in the SPECT market?
Bracco Imaging, Siemens Healthcare, and Novartis AG are prominent companies in the market.
Which are the top 3 countries in the market for SPECT?
The U.S., China, and Canada are the top 3 countries in the market.
At what pace is the Canada SPECT market expected to evolve?
The market in Canada is set to rise at 6.5% CAGR through 2026.
Which segment is leading in the SPECT market?
Standalone systems account for 55% share of the SPECT market.
Single Photon Emission Computed Tomography (SPECT) Market